Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - DNIB UNWIND, INC. | d837520dex321.htm |
| EX-21.1 - EX-21.1 - DNIB UNWIND, INC. | d837520dex211.htm |
| EX-32.2 - EX-32.2 - DNIB UNWIND, INC. | d837520dex322.htm |
| EX-31.1 - EX-31.1 - DNIB UNWIND, INC. | d837520dex311.htm |
| EXCEL - IDEA: XBRL DOCUMENT - DNIB UNWIND, INC. | Financial_Report.xls |
| 10-K - 10-K - DNIB UNWIND, INC. | d837520d10k.htm |
| EX-31.2 - EX-31.2 - DNIB UNWIND, INC. | d837520dex312.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-199105 on Form S-3 and Registration Statement Nos. 333-194792 and 333-191297 on Form S-8 of our report dated March 11, 2015, relating to the financial statements of BIND Therapeutics, Inc. appearing in this Annual Report on Form 10-K of BIND Therapeutics, Inc. for the year ended December 31, 2014.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
March 11, 2015